Sprycel receives FDA approval for front line usage in newly diagnosed CML patients.

Submitted by admin1 on Tue, 2010-11-02 20:35

Bristol-Myers Squibb recently received FDA approval for the usage of Sprycel (Dasatinib) in newly diagnosed patients. This is good news for our community as it gives yet another option in our armamentarium of drugs.

Read the press release now.

Ask the CML ExpertsTM

Since CML is a rare form of leukemia, we know there's a need for many types of expert information. That's why we've developed the Ask the CML Experts™ portal. Interacting with medical professionals who specialize in CML treatment is just a click away!

View CML Questions

Meet Our Panel

CML ConnectionTM

CML Connection™ lets you find and build support at the local level. The Society provides information on medical providers and is building support groups across the country. These groups provide a way to connect with others, discuss local CML news, gain a perspective of the CML community at the national level and provide feedback on how the NCMLS can best meet your unique needs.

Find Local CML Resources